Psychiatric symptoms in patients with non-valvular atrial fibrillation (vol 29, 105, 2022)

被引：0
|
作者：
Yossef, Manar [1 ]
Amer, Reham [1 ]
Elsokkary, Hatem [2 ]
Shama, Gamal [1 ]
机构：
[1] Tanta Univ, Fac Med, Psychiat & Neurol Dept, Tanta, Egypt
[2] Tanta Univ, Fac Med, Cardiol Dept, Tanta, Egypt
来源：
MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH | 2023年 / 30卷 / 01期
关键词：
D O I：
10.1186/s43045-023-00292-7
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Screening for asymptomatic carotid stenosis in patients with non-valvular atrial fibrillation
    Paraskevas, Kosmas I.
    Eckstein, Hans-Henning
    Mansilha, Armando
    Ricco, Jean-Baptiste
    Geroulakos, George
    Di Lazzaro, Vincenzo
    Rundek, Tatjana
    Lanza, Gaetano
    Fraedrich, Gustav
    Svetlikov, Alexei S.
    Suri, Jasjit S.
    Zeebregts, Clark J.
    Davies, Alun H.
    Capoccia, Laura
    Proczka, Robert M.
    Myrcha, Piotr
    Antignani, Pier Luigi
    Fernandes e Fernandes, Jose
    Spence, J. David
    Dardik, Alan
    Jezovnik, Mateja K.
    Knoflach, Michael
    Lavenson, George S., Jr.
    Kakkos, Stavros K.
    Jawien, Arkadiusz
    Silvestrini, Mauro
    Blinc, Ales
    Spinelli, Francesco
    Stilo, Francesco
    Musialek, Piotr
    Sultan, Sherif
    Goudot, Guillaume
    Liapis, Christos
    Saba, Luca
    Faggioli, Gianluca
    Pini, Rodolfo
    Poredos, Pavel
    Mikhailidis, Dimitri P.
    Gloviczki, Peter
    Nicolaides, Andrew N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 372 : 120 - 121
  • [42] Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
    Kocis P.T.
    Liu G.
    Makenbaeva D.
    Trocio J.
    Velott D.
    Trainer J.A.B.
    Abdulsattar Y.
    Molina M.I.
    Leslie D.L.
    Drugs - Real World Outcomes, 2016, 3 (2) : 165 - 173
  • [43] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [44] Evaluation of the Level of Anticoagulation Control in Patients with Non-Valvular Atrial Fibrillation
    Zang, Bill
    Setakis, Efrosini
    van Staa, Tjeerd P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S113 - S114
  • [45] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [46] Factors Associated with Outcome in Stroke Patients with Non-Valvular Atrial Fibrillation
    Maruyama, Kenji
    Shiga, Tsuyoshi
    Iijima, Mutsumi
    Uchiyama, Shinichiro
    Kitagawa, Kazuo
    CEREBROVASCULAR DISEASES, 2014, 38 : 65 - 66
  • [47] Left Atrial Appendage Closure for Non-valvular Atrial Fibrillation
    Incani, Alexander
    Lee, Joseph C.
    Poon, Karl K.
    Burstow, Darryl J.
    Raffel, O. Christopher
    Walters, Darren L.
    HEART LUNG AND CIRCULATION, 2012, 21 (04): : 247 - 248
  • [48] Venous Thromboembolism and Atherosclerotic Events in Patients With Non-Valvular Atrial Fibrillation
    Thomopoulos, Costas
    ANGIOLOGY, 2022, 73 (05) : 393 - 394
  • [49] The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation
    Burnett, Allison
    Tiongson, Jay
    Downey, Ross
    Mahan, Charles E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) : 1119 - 1133
  • [50] CAUSES OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL-FIBRILLATION (NVAF)
    BOGOUSSLAVSKY, J
    VANMELLE, G
    REGLI, F
    KAPPENBERGER, L
    STROKE, 1990, 21 (01) : 174 - 174
12345